News

New Nomograms Predict Lymphedema After Axillary Lymph Node Dissection

Publish date: September 7, 2011

 

FROM A BREAST CANCER SYMPOSIUM SPONSORED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Dr. Bevilacqua reported that he had no relevant conflicts of interest.

Pages

Recommended Reading

Vemurafenib Will Open Floodgates for Melanoma Genotyping
MDedge Internal Medicine
Uncertainty Rules Adjuvant Chemo for Early HER2 Breast Cancer
MDedge Internal Medicine
Cancer Stage Not a Significant Factor in Radioiodine Use
MDedge Internal Medicine
Smoking-Bladder Cancer Link Strengthened - Especially in Women
MDedge Internal Medicine
FDA Approves Vemurafenib for Advanced Melanoma
MDedge Internal Medicine
ATHENA: HPV Testing Outperforms Cytology for Cervical Cancer Screening
MDedge Internal Medicine
NSCLC: FDA Approves Crizotinib, Companion Diagnostic Test
MDedge Internal Medicine
New Diarrheal Syndrome Tied to Cord-Blood Transplants
MDedge Internal Medicine
Crizotinib Approval Personalizes Lung Cancer Therapy
MDedge Internal Medicine
Study Supports Palpation, Mammography Regardless of Age
MDedge Internal Medicine